← Back to Clinical Trials
Recruiting NCT07190963

NCT07190963 MindRhythm Detection of Concussion and Recovery Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07190963
Status Recruiting
Phase
Sponsor MindRhythm, Inc.
Condition mTBI - Mild Traumatic Brain Injury
Study Type OBSERVATIONAL
Enrollment 150 participants
Start Date 2025-01-28
Primary Completion 2027-01-28

Eligibility & Interventions

Sex All sexes
Min Age 4 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 150 participants in total. It began in 2025-01-28 with a primary completion date of 2027-01-28.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is designed to observe HeadPulse data in concussed subjects that may have experienced a concussion via an injury down to the age of 4. Sports teams are the focus of this study because therein lies inherent potential risk for concussion. This observational study will further confirm the data previously collected in professional athletes to further validate that the HeadPulse can be used as a digital biometric to objectively indicate when a concussed brain remains concussed despite a subject feeling no symptoms has extreme value. This study is intended to support the development of a device to objectively determine when it is safe to return to play or normal activity based on the output of the digital biometric.

Eligibility Criteria

Inclusion Criteria: An individual who has been diagnosed with or suspected to have a concussion or mTBI. \- Exclusion Criteria: open wounds on the head. Pregnant women due to unexpected risks. Subjects under the age of 4. \-

Contact & Investigator

Central Contact

Beth Johnson-Reich

✉ beth.johnson@mindrhythm.com

📞 8608368630

Frequently Asked Questions

Who can join the NCT07190963 clinical trial?

This trial is open to participants of all sexes, aged 4 Years or older, studying mTBI - Mild Traumatic Brain Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07190963 currently recruiting?

Yes, NCT07190963 is actively recruiting participants. Contact the research team at beth.johnson@mindrhythm.com for enrollment information.

Where is the NCT07190963 trial being conducted?

This trial is being conducted at Cupertino, United States, Cupertino, United States.

Who is sponsoring the NCT07190963 clinical trial?

NCT07190963 is sponsored by MindRhythm, Inc.. The trial plans to enroll 150 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology